太醫 Stock: price and insider trades · Taiwan
太醫: what insiders have been doing
This page follows insider dealings at 太醫 as filed with TWSE / TPEx (MOPS), a company from the Health Care sector. The last twelve months, up to 22 October 2026, brought 2 filings signed by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 620 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark.
There has been no open-market purchase by an insider of 太醫 for at least a year.
This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About 太醫
太醫 is a company listed on the XTAI market, specializing in the healthcare sector. It focuses on developing innovative medical solutions.
